Cargando…
Engineering Neprilysin Activity and Specificity to Create a Novel Therapeutic for Alzheimer’s Disease
Neprilysin is a transmembrane zinc metallopeptidase that degrades a wide range of peptide substrates. It has received attention as a potential therapy for Alzheimer’s disease due to its ability to degrade the peptide amyloid beta. However, its broad range of peptide substrates has the potential to l...
Autores principales: | Webster, Carl I., Burrell, Matthew, Olsson, Lise-Lotte, Fowler, Susan B., Digby, Sarah, Sandercock, Alan, Snijder, Arjan, Tebbe, Jan, Haupts, Ulrich, Grudzinska, Joanna, Jermutus, Lutz, Andersson, Christin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121237/ https://www.ncbi.nlm.nih.gov/pubmed/25089527 http://dx.doi.org/10.1371/journal.pone.0104001 |
Ejemplares similares
-
Sustained peripheral depletion of amyloid-β with a novel form of neprilysin does not affect central levels of amyloid-β
por: Henderson, Simon J., et al.
Publicado: (2014) -
Neprilysin Inhibits Coagulation through Proteolytic Inactivation of Fibrinogen
por: Burrell, Matthew, et al.
Publicado: (2016) -
Neprilysin in HFrEF: Differential Regulation of Tissue Versus Circulating Neprilysin
por: Chen, Horng H., et al.
Publicado: (2020) -
Identification and bioinformatic analysis of neprilysin and neprilysin-like metalloendopeptidases in Drosophila melanogaster
por: Meyer, Heiko, et al.
Publicado: (2021) -
Neprilysin Inhibitors and Bradykinin
por: Campbell, Duncan J.
Publicado: (2018)